MammaPrint guides treatment decisions in breast Cancer: results of the IMPACt trial

MammaPrint guides treatment decisions in breast Cancer: results of the IMPACt trial

Abstract Background Increased usage of genomic risk assessment assays suggests increased reliance on data provided by these assays to guide therapy decisions. The current study aimed to assess the change in treatment decision and physician confidence based on the 70-gene risk of recurrence signature...

Full description

Bibliographic Details
Main Authors: Hatem Soliman, Varsha Shah, Gordan Srkalovic, Reshma Mahtani, Ellis Levine, Blanche Mavromatis, Jayanthi Srinivasiah, Mohamad Kassar, Robert Gabordi, Rubina Qamar, Sarah Untch, Heather M. Kling, Tina Treece, William Audeh
Format: Article
Language:English
Published: BMC 2020-01-01
Series:BMC Cancer
Subjects:
Breast cancer
Diagnostic test
MammaPrint
BluePrint
70-GS
80-GS
Online Access:https://doi.org/10.1186/s12885-020-6534-z

Internet

https://doi.org/10.1186/s12885-020-6534-z

Similar Items